Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Toxic epidermal necrolysis? 110 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Toxic epidermal necrolysis have been filed in association with CYTARABINE (cytarabine). This represents 0.3% of all adverse event reports for CYTARABINE.

110
Reports of Toxic epidermal necrolysis with CYTARABINE
0.3%
of all CYTARABINE reports
53
Deaths
59
Hospitalizations

How Dangerous Is Toxic epidermal necrolysis From CYTARABINE?

Of the 110 reports, 53 (48.2%) resulted in death, 59 (53.6%) required hospitalization, and 20 (18.2%) were considered life-threatening.

Is Toxic epidermal necrolysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 110 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Toxic epidermal necrolysis?

ACETAMINOPHEN (980) LAMOTRIGINE (941) ALLOPURINOL (858) IBUPROFEN (764) SULFAMETHOXAZOLE\TRIMETHOPRIM (592) CIPROFLOXACIN (576) FUROSEMIDE (521) VANCOMYCIN (515) PIPERACILLIN\TAZOBACTAM (490) PEMBROLIZUMAB (444)

Which CYTARABINE Alternatives Have Lower Toxic epidermal necrolysis Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Toxic epidermal necrolysis Reports All Drugs Causing Toxic epidermal necrolysis CYTARABINE Demographics